CompanyGraph
Top Glove Corporation Bhd
7113 · Malaysia
Price data from its TPGVF listing on OTC, quoted in USD
topglove.comFinancials as of FY2025
At a glance
- Depends onUpstream position: supplies 5 industries, depends on 1
- ScaleRevenue is $951.57M, above the global median of $548.88M
- FinancialsAltman Z-Score 3.67: safe zone
- Interpretations2 currently firing — 2
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
1.25%Below 5Y avg (6.37%)
Annual Rate
MYR 0.01Paid semi-annual
Payout Ratio
20.9%Sustainable
Payback Period
11.3 yr
Last Ex-Dividend
Nov 24, 2025
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
4.77BMYR1.17B · vs all stocks (USD)
Trailing P/E
38.00xvs Medical Instruments & Supplies peers
Revenue (TTM)
3.88BMYR951.57M · vs all stocks (USD)
Profit Margin
4.78%vs Medical Instruments & Supplies peers
Beta
0.4570xvs all stocks
52-Week Change
29.66%vs all stocks
Forward Annual Dividend Yield
1.25%vs all stocks
Market Capitalization
4.77BMYR1.17B · vs all stocks (USD)
Enterprise Value
6.33BMYR1.55B · vs all stocks (USD)
Trailing P/E
38.00xvs Medical Instruments & Supplies peers
Forward P/E
26.86xvs Medical Instruments & Supplies peers
PEG Ratio
0.2817xvs Medical Instruments & Supplies peers
Price to Sales (TTM)
1.57xvs Medical Instruments & Supplies peers
Price to Book (MRQ)
1.27xvs Medical Instruments & Supplies peers
Enterprise to Revenue
1.63xvs Medical Instruments & Supplies peers
Enterprise to EBITDA
14.18xvs Medical Instruments & Supplies peers
Profit Margin
4.78%vs Medical Instruments & Supplies peers
Operating Margin
13.71%vs Medical Instruments & Supplies peers
Return on Assets (TTM)
1.39%vs Medical Instruments & Supplies peers
Return on Equity (TTM)
3.79%vs Medical Instruments & Supplies peers
Revenue (TTM)
3.88BMYR951.57M · vs all stocks (USD)
Revenue per Share (TTM)
0.4840MYRUpdated Sep 22, 2026Quarterly Revenue Growth
31.90%vs Medical Instruments & Supplies peers
Gross Profit (TTM)
657.25MMYR161.30M · vs all stocks (USD)
EBITDA (TTM)
622.60MMYR152.80M · vs all stocks (USD)
Net Income (TTM)
185.16MMYR45.44M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
133.10%vs Medical Instruments & Supplies peers
Operating Cash Flow (TTM)
487.75MMYR119.70M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
272.33MMYR66.83M · vs all stocks (USD)
Forward Annual Dividend Rate
0.0096MYRUpdated Sep 22, 2026Forward Annual Dividend Yield
1.25%vs all stocks
Trailing Annual Dividend Rate
0.0168MYRUpdated Sep 22, 2026Trailing Annual Dividend Yield
2.20%vs all stocks
5-Year Average Dividend Yield
6.37%vs all stocks
Payout Ratio
20.87%vs Medical Instruments & Supplies peers
Minority Interest (Equity)
25.55MMYRFY2025 · Aug 31, 2025Revenue
3.49BMYRFY2025 · Aug 31, 2025Cost of Goods Sold
3.00BMYRFY2025 · Aug 31, 2025Gross Profit
496.88MMYRFY2025 · Aug 31, 2025Operating Income
22.07MMYR5.42M · vs all stocks (USD)
Pre-tax Income
148.20MMYRFY2025 · Aug 31, 2025Income Tax Expense
25.35MMYRFY2025 · Aug 31, 2025Net Income
122.85MMYRFY2025 · Aug 31, 2025EBIT
170.41MMYRFY2025 · Aug 31, 2025EBITDA (Income Statement)
411.34MMYRFY2025 · Aug 31, 2025Selling, General & Administrative
481.02MMYRFY2025 · Aug 31, 2025Other Operating Expenses
-57.00KMYRFY2025 · Aug 31, 2025Non-operating Interest Income
28.52MMYRFY2025 · Aug 31, 2025Non-operating Interest Expense
22.21MMYRFY2025 · Aug 31, 2025EPS (Basic)
0.0131MYRFY2025 · Aug 31, 2025EPS (Diluted)
0.0131MYRFY2025 · Aug 31, 2025Minority Interests (P&L)
5.60MMYRFY2025 · Aug 31, 2025Operating Cash Flow
106.32MMYRFY2025 · Aug 31, 2025Free Cash Flow
91.58MMYRFY2025 · Aug 31, 2025Cash & Cash Equivalents (End of Period)
296.95MMYRFY2025 · Aug 31, 2025Starting Profit (CF Statement)
148.20MMYRFY2025 · Aug 31, 2025Stock-based Compensation
257.00KMYRFY2025 · Aug 31, 2025Other Non-cash Items
-6.33MMYRFY2025 · Aug 31, 2025Change in Accounts Receivable (CF)
-80.78MMYRFY2025 · Aug 31, 2025Change in Other Assets/Liabilities
44.98MMYRFY2025 · Aug 31, 2025Capital Expenditures
14.74MMYRFY2025 · Aug 31, 2025Net Intangibles (CF)
-399.00KMYRFY2025 · Aug 31, 2025Net Acquisitions
0.00MYRFY2025 · Aug 31, 2025Purchase of Investments
-178.19MMYRFY2025 · Aug 31, 2025Sale of Investments
576.66MMYRFY2025 · Aug 31, 2025Other Investing Activity
15.43MMYRFY2025 · Aug 31, 2025Net Investing Cash Flow
428.63MMYRFY2025 · Aug 31, 2025Long-term Debt Issuance
1.19BMYRFY2025 · Aug 31, 2025Long-term Debt Payments
-796.86MMYRFY2025 · Aug 31, 2025Other Financing Charges
-1.20BMYRFY2025 · Aug 31, 2025Net Financing Cash Flow
-799.43MMYRFY2025 · Aug 31, 2025Shares Outstanding
8.02BSharesUpdated Sep 22, 2026Float Shares
4.94BSharesUpdated Sep 22, 2026% Held by Insiders
38.27%vs all stocks
% Held by Institutions
20.78%vs all stocks
Total Cash (MRQ)
770.56MMYR189.11M · vs all stocks (USD)
Total Cash per Share (MRQ)
0.0960MYRUpdated Sep 22, 2026Total Debt (MRQ)
862.43MMYR211.66M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.1784xvs Medical Instruments & Supplies peers
Current Ratio (MRQ)
2.51xvs Medical Instruments & Supplies peers
Book Value per Share (MRQ)
0.6000MYRUpdated Sep 22, 2026Total Assets
6.28BMYR1.54B · vs all stocks (USD)
Total Current Assets
1.45BMYRFY2025 · Aug 31, 2025Total Liabilities
1.50BMYRFY2025 · Aug 31, 2025Total Non-current Assets
4.82BMYRFY2025 · Aug 31, 2025Total Non-current Liabilities
961.50MMYRFY2025 · Aug 31, 2025Total Current Liabilities
538.30MMYRFY2025 · Aug 31, 2025Cash
295.97MMYRFY2025 · Aug 31, 2025Cash & Cash Equivalents
295.97MMYRFY2025 · Aug 31, 2025Other Short-term Investments
262.51MMYRFY2025 · Aug 31, 2025Accounts Receivable
423.39MMYRFY2025 · Aug 31, 2025Inventory
344.92MMYRFY2025 · Aug 31, 2025Accounts Payable
196.08MMYRFY2025 · Aug 31, 2025Retained Earnings
4.21BMYRFY2025 · Aug 31, 2025Total Shareholders' Equity
4.78BMYR1.17B · vs all stocks (USD)
52-Week Low
0.5300MYRUpdated Sep 22, 202652-Week High
0.8800MYRUpdated Sep 22, 202652-Week Change
29.66%vs all stocks
Beta
0.4570xvs all stocks
50-Day MA
0.6701MYRUpdated Sep 22, 2026200-Day MA
0.6729MYRUpdated Sep 22, 2026Avg 10-Day Volume
67.48MSharesUpdated Sep 22, 2026Avg 30-Day Volume
35.77MSharesUpdated Sep 22, 2026Diluted EPS (TTM)
0.0200MYRUpdated Sep 22, 20262 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsHow does this company use capital?
Working Capital Pattern
What customers owe has grown three years running, while it clears stock quickly and pays suppliers quickly.
Reads
Where is this company structurally exposed?
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 3.67: safe zoneNotable
Altman Z-Score: 3.67
Supply Chain
Upstream position: supplies 5 industries, depends on 1Notable
Outgoing: 5.00Incoming: 1.00
Scale
Revenue is $951.57M, above the global median of $548.88MNotable
Revenue (USD): 951,571,858.693Global Median: 548,883,780.48
Levered free cash flow is $66.83M, above the global median of $18.73MNotable
Levered free cash flow (USD): 66,834,580.691Global Median: 18,729,043.027
Companies that share the same coordination system — how they create, deliver, or capture value.
Jiangsu Zongyi Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRisk
Nanjing Chemical Fibre Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Techwing Inc.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Taiwan Hon Chuan Enterprise Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Goldsun Building Materials Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Fujian Acetron New Materials Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Pilot Corp.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Cyient Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingFlow
Hengbao Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Kunshan Guoli Electronic Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Wiwynn Corporation
2 interpretationsWorking Capital PatternUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
Ningbo KBE Electrical Technology Co., Ltd.
2 interpretationsWorking Capital PatternUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
Ies Holdings Inc.
2 interpretationsWorking Capital PatternUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated